Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
about
Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
description
clinical trial
@en
klinisch onderzoek
@nl
name
Talimogene Laherparepvec and N ...... tory Non-melanoma Skin Cancers
@en
type
label
Talimogene Laherparepvec and N ...... tory Non-melanoma Skin Cancers
@en
prefLabel
Talimogene Laherparepvec and N ...... tory Non-melanoma Skin Cancers
@en
P1050
P6153
P1050
P1476
A Phase II Study of Talimogene ...... ma, and Other Rare Skin Tumors
@en
P3098
NCT02978625
P580
2017-09-18T00:00:00Z
P582
2020-01-01T00:00:00Z